Osaic Holdings’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91K Buy
470
+190
+68% +$1.73K ﹤0.01% 6851
2026
Q1
$1.98K Sell
280
-235
-46% -$1.66K ﹤0.01% 7050
2025
Q4
$2.55K Sell
515
-220
-30% -$927 ﹤0.01% 6997
2025
Q3
$3.26K Buy
735
+220
+43% +$749 ﹤0.01% 6964
2025
Q2
$1.61K Buy
515
+115
+29% +$324 ﹤0.01% 7011
2025
Q1
$1K Sell
400
-115
-22% -$361 ﹤0.01% 6814
2024
Q4
$1.6K Hold
515
﹤0.01% 6697
2024
Q3
$1.23K Hold
515
﹤0.01% 6776
2024
Q2
$1.3K Buy
+515
New +$1.31K ﹤0.01% 6741

Other funds holding DRTS

Osaic Holdings's DRTS Position: Q2 2026 in Review

Osaic Holdings increased its Alpha Tau Medical (DRTS) stake by 68% in Q2 2026, buying an estimated $1.73K and bringing the position to 470 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #6851.

Osaic Holdings first reported a position in DRTS in Q2 2024 and has held it in 9 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Osaic Holdings held 470 shares of Alpha Tau Medical worth $5.91K as of Q2 2026.
  • Osaic Holdings bought 190 Alpha Tau Medical shares in Q2 2026, an estimated $1.73K.
  • Alpha Tau Medical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6851 holding.
  • Osaic Holdings first reported a position in Alpha Tau Medical in Q2 2024 and has held it in 9 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.